Inter-α-trypsin inhibitor (ITI) is a complex that consists of three components. One of these is the acid-stable proteinase inhibitor (ASPI), which is an acutephase reactant and a broad-spectrum inhibitor. The tissue distribution of ITI and ASPI were investigated and compared using immunohistochemical methods. ITI immunoreactivity was revealed only in the liver and plasma, while ASPI immunoreactivity was found to be distributed in the brain, liver, kidney, gastrointestinal tract, plasma, and urine. Both immunoreactivities were demonstrated in Kupffer cells of the liver, which is thought to be an ITI-producing organ. From these results, it seems unlikely that ASPI is distributed as a part of the ITI molecule. The residual component of ITI may act as a carrier protein of ASPI, or ASPI in the tissues may be produced independently of ITI.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Heimburger, N., H. Haupt, andH. G. Schwick. 1971. Proteinase inhibitors of human plasma.In Proceedings of the International Research Conference on Proteinase Inhibitors 1970, H. Frits and H. Tschesche, editors. Walter de Grayter, Berlin, 1–22.
Pratt, C. W., P. A. Roche, andS. V. Pizzo. 1987. The role of inter-α-trypsin inhibitor and other proteinase inhibitors in the plasma clearance of neutrophil elastase and plasmin.Arch. Biochem. Biophys. 258:591–599.
Smith, J. M., M. B. Balabanian, R. M. Freeman. 1976. Serum levels of a component reacting with antiserum to urinary antitrypsin in health and disease with emphasis on high levels in renal failure.J. Lab. Clin. Med. 88:904–913.
Toki, N., H. Sumi. 1982. Urinary trypsin inhibitor and urokinase activities in renal diseases.Acta Haematol. 67:110–114.
Frank, C., J. Z. Pedersen. 1983. Trypsin-inhibitory activities of acid-stable fragments of the inter-alpha-trypsin inhibitor in inflammatory and uraemic conditions.Scand. J. Clin. Lab. Invest. 43:151–155.
Mizon, C., M. Balduyck, J. P. Bonneterre, J. Mizon. 1983. Urinary trypsin inhibitory capacity determination: study in patients with disseminated cancers.Bull. Cancer 70:266–270.
Ødum, L., G. Hasen-Nord, I. Byrjalsen. 1987. Human inter-α-trypsin inhibitor and immunologically related inhibitors investigated by quantitative immunoelectrophoresis. II. Pathological conditions.Clin. Chim. Acta 162:189–198.
Bourguignon, J., D. Vercaigne, R. Sesboüé, J. P. Martin, J. P. Salier. 1983. Inter-alphatrypsin inhibitor (ITI): two distinct mRNAs in baboon liver argue for a discrete synthesis of ITI and ITI derivatives.FEBS Lett. 162:379–383.
Schreitmüller, T., K. Hochstrasser, P. W. M. Reisinger, E. Wachter, W. Gebhard. 1987. cDNA cloning human inter-α-trypsin inhibitor discloses three different proteins.Biol. Chem. Hoppe-Seyler 368:963–970.
Balduyck, M., S. Laroui, C. Mizon, andJ. Mizon. 1989. A proteoglycan related to the urinary trypsin inhibitor (UTI) links the two heavy chains of inter-α-trypsin inhibitor.Biol. Chem. Hoppe-Seyler 370:329–336.
Gebhard, W., T. Schreitmüller, K. Hochstrasser, E. Wachter. 1989. Two out of the three kinds of subunits of inter-α-trypsin inhibitor are structurally related.Eur. J. Biochem. 181:571–576.
Enghild, J. J., I. B. ThØgersen, S. V. Pizzo, G. Salvesen. 1989. Analysis of inter-α-trypsin inhibitor and a novel trypsin inhibitor, pre-α-trypsin inhibitor, from human plasma.J. Biol. Chem. 264:15975–15981.
Deitl, T., W. Dobrinski, K. Hochstrasser. 1979. Human inter-α-trypsin inhibitor. Limited proteolysis by trypsin, plasmin, kallikrein and granulocytic elastase and inhibitory properties of the cleavage products.Hoppe-Seyler's Z. Physiol. Chem. 360:1313–1318.
Salier, J. P., R. Sesboüé, K. Hochstrasser, ö. Schönberger, J. P. Martin. 1983. Isolation and characterization of an inter-α-trypsin inhibitor-IgG complex from human serum.Biochim. Biophys. Acta 742:206–214.
McKeehan, W. L., Y. Sakagami, H. Hoshi, K. A. McKeehan. 1986. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors.J. Biol. Chem. 261:5378–5383.
Yoshida, E., H. Sumi, M. Maruyama, H. Tsushima, Y. Matsuoka, M. Sugiki, H. Mihara 1989. Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues.Cancer 64:860–869.
Sumi, H., Y. Takada, A. Takada. 1977. Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid.Thromb. Res. 11:747–754.
Laroui, S., M. Balduyck, C. Mizon, L. Selloum, andJ. Mizon. 1988. Plasma proteins immunologically related to inter-α-trypsin inhibitor.Biochim. Biophys. Acta 953:263–268.
Yoshida, E., H. Sumi, M. Maruyama, H. Mihara, R. Sakai. 1987. Development and application of an enzyme-linked immunosorbent assay for acid stable trypsin inhibitor (ASTI) in human plasma.Clin. Chim. Acta. 167:155–164.
Kaumeyer, J. F., J. O. Polazzi, M. P. Kotick. 1986. The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-α-trypsin inhibitor also encodesα-1-microglobulin (protein HC).Nucleic Acids Res. 14:7839–7850.
Salier, J. P., M. Diarra-Mehrpour, R. Sesboüé, J. Bourguignon, R. Benarous, I. Oh-Kubo, S. Kurachi, K. Kurachi, J.P. Martin. 1987. Isolation and characterization of cDNAs encoding the heavy chain of human inter-α-trypsin inhibitor (Iα TI): Unambiguous evidence for multipolypeptide chain structure of Iα TI.Proc. Natl. Acad. Sci. U.S.A. 84:8272–8276.
About this article
Cite this article
Yoshida, E., Sumi, H., Tsushima, H. et al. Distribution and localization of inter-α-trypsin inhibitor and its active component acid-stable proteinase inhibitor: Comparative immunohistochemical study. Inflammation 15, 71–79 (1991). https://doi.org/10.1007/BF00917911
- Public Health
- Internal Medicine
- Proteinase Inhibitor
- Gastrointestinal Tract
- Active Component